ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Other Current Assets history
Currency unavailable · from the balance sheet
No Other Current Assets data reported for this period type.
Other Current Assets vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $10.56M USD | -35.7% | — | 9.2% | |
| Mar 2026 | $6.88M USD | +34.6% | +14.1% | 1.6% | |
| Mar 2026 | $4.16M USD | -89.2% | -17.0% | 1.7% | |
| Mar 2026 | $3.46M USD | -49.5% | +13.4% | 0.6% | |
| Mar 2026 | $2.39M USD | -85.5% | +144.9% | 0.8% | |
| Mar 2026 | $1.25M USD | +195.5% | +275.5% | 0.7% | |
| Mar 2026 | $670K USD | +10.6% | -2.9% | 0.3% | |
| Mar 2026 | $138K USD | — | — | 0.0% | |
| Mar 2026 | €0 EUR | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -35.7% | +13.8% | 0.7% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.